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In our recent publication, some textual errors related to the presentation of the figures, legends, or text was brought to our attention.
We would like to thank the reader whose thorough reading and keen examination brought these errors to our attention.
In the description for Figure 3 on page 279 (line 7, right column), the increase in lesion size should refer to Figures 3A–3C, not 3A and
3B. Likewise, the description for bacterial counts on page 279 (line 10, right column) should refer to 3D and 3E, not 3C and 3D.
On page 281 (line 7, left column), it should read, ‘‘. mice exhibited a further significant reduction in the expression of the mouse
cathelicidin gene Camp (55% reduction) and mouse b-defensin 3 (mBD3) (70% reduction).’’
The figure legend for Figure 5A should read, ‘‘.mouse beta-defensin 3 was calculated by qPCR.’’ instead of ‘‘human beta-defen-
sins 4 and 14 (DefB4 and DefB14).’’
The figure legend for Figure 6 is duplicated from (C). Figure Legend 6 should read as so:
(A) Keratinocytes were stimulated for 24 hr with 1,25 (OH)2 Vitamin D3 (VD3) and MALP-2 in the presence or absence of Ach (Ach) or
catestatin (Cst). Relative mRNA expression of cathelicidin (Camp) (left) and human beta-defensin 2 (DefB2) (right) by qPCR and
normalized to GAPDH. *p < 0.05 versus VD3+MALP-2 by one-way ANOVA. p > 0.05 with Cst.
(B) Keratinocytes were stimulated for 24 hr with 1,25 (OH)2 Vitamin D3 (VD3) and MALP-2 in the presence or absence of Ach (Ach) or
a-Bungarotoxin (Bung). Relative mRNA expression of cathelicidin (Camp) (left) and human beta-defensin 2 (DefB2) (right) by qPCR
and normalized to GAPDH. *p < 0.05 versus VD3+MALP-2 by one-way ANOVA. p > 0.05 with Bung.
(C) Keratinocytes were stimulated as above and cell lysates incubated with S. aureus DmprF. Surviving bacteria after 12 hr is shown.
*p < 0.05 versus VD3+MALP-2 by one-way ANOVA. p > 0.05 with Cst and a-Bungarotoxin antagonists. All data are represented as
mean ± SEM.
We regret these oversights and apologize for any confusion with our results.552 Cell Host & Microbe 8, 552, December 16, 2010 ª2010 Elsevier Inc.
